Where does Nuwacell's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Nuwacell's 2 recorded funding rounds.

Premier Alternatives

Nuwacell

Biotech · Hefei, Anhui · Founded 2016 · Privately Held (backing)

Developer of cell therapy products designed for Induced Pluripotent Stem Cells (iPSC). Nuwacell is based in Hefei, Anhui and was founded in 2016. Its last reported valuation was $203 million in Jun 2022. It has raised $63.7 million across 2 recorded rounds; the latest was an $11.6 million Series B (final close) in Apr 2025.

Last reported valuation

$202.5M

Oct 2026

Priced at

—

Total raised

$63.7M

Last round

Series B (final close)

Apr 2025

Cap table — not yet on record

Nuwacell's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Nuwacell with a free account

·The complete investor list: 11 names
·Everyone on the team, board and advisors included
·Watch Nuwacell: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Nuwacell

Where does Nuwacell's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Nuwacell's 2 recorded funding rounds.